Healthcare -
Biotechnology - NASDAQ - US
$ 53.55
-0.557 %
$ 6.6 B
Market Cap
14.24
P/E
HALO - OPERATING INCOME
Operating Income HALO - Halozyme Therapeutics, Inc.
551 M
LAST VALUE
43.57%
2 YEAR CAGR
58.98%
5 YEAR CAGR
26.80%
10 YEAR CAGR